Dexpanthenol nasal spray in comparison to dexpanthenol nasal ointment. A prospective, randomised, open, cross-over study to compare nasal mucociliary clearance;Dexpanthenol - Nasenspray vs. Nasensalbe: Prospektive, randomisierte, offene cross-over-studie zur mukoziliaren clearance

HNO

Volumn 52, Issue 7, 2004, Pages 611-615

  Verse, T ^a,d   Klocker N ^b   Riedel, F ^a   Pirsig, W ^c   Scheithauer, M O ^c  

^a Univ Hals Nasen Ohren K Mannheim   (Germany)

^b AUDIT Inst Med Serv/Qual Assur   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Dexpanthenol; Nasal ointment; Nasal spray; Saccharine test; Tolerance

Indexed keywords

DEXPANTHENOL; NOSE SPRAY; PRESERVATIVE; SACCHARIN; XYLOMETAZOLINE;

AGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DRUG FORMULATION; DRUG TOLERANCE; HUMAN; HUMAN EXPERIMENT; MUCOCILIARY CLEARANCE; NORMAL HUMAN; NOSE MUCOSA; OINTMENT; OPEN STUDY; OUTCOMES RESEARCH; PROSPECTIVE STUDY; RANDOMIZATION; TIME; VOLUNTEER;

EID: 3142690969     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-003-0961-4     Document Type: Conference Paper

References (32)

1. Andersen I, Camner P, Jensen PL, Philipson K, Proctor DF (1974) Nasal clearance in monocygotic twins. Am Rev Respir Dis 110: 301-305
2. Bachert C (1998) Die Wirkung von Benzalkoniumchlorid auf das Flimmereithel der Schleimhaut. HNO 46: 90-92
3. Berg OH, Lie K, Steinsvag SK (1997) The effects of topical nasal steroids on rat respiratory mucosa in vivo, with special reference to benzalkonium chloride. Allergy 52: 627-632
4. Bernstein IL (2000) Is the use of benzalkonium chloride as a preservative for nasal formulations a safety concern? A cautionary note based on compromised mucociliary transport. J Allergy Clin Immunol 105: 39-44
5. Bleeker JDJW, Koeksema PE (1971) A simple method to measure the ciliary beat rate of respiratory epithelium. Acta Otolaryngol 71: 426-429
6. Boek WM, Romeijn SG, Graamans K, Verhoef JC, Merkus FW, Huizing EH (1999) Validation of animal experiments on ciliary funktion in vitro. II. The influence of absorption enhancers, preservatives and physiologic saline. Acta Otolaryngol 119: 98-101
7. Bommer R (1999) Latest advances in nasal drug-delivery technology. Med Device Technol 10: 22-28
8. Cho JH, Kwun YS, Jang HS, Kang JM, Won YS, Yoon HR (2000) Long-term use of preservatives on rat nasal respiratory mucosa: effects of benzalkonium chloride and potassium sorbat. Laryngoscope 110: 312-317
9. Constantinidis J, Knobber D, Steinhart H, Kuhn J, Iro H (2000) Morphologische und funktionelle Veränderungen der Nasenschleimhaut nach nCPAP-Therapie. HNO 48: 747-752
10. Deitmer T (1986) A modification of the saccharine test for nasal mucociliary clearance. Rhinology 24: 237-240
11. Edelstein DR (1996) Aging of the normal nose in adults. Laryngoscope 106: 1-25
12. Graf P, Hallén H (1996) Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Laryngoscope 106: 605-609
13. Graf P, Enerdal J, Hallén H (1999) Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis. Arch Otolaryngol Head Neck Surg 103: 1128-1132
14. Hady MRA, Shehata O, Hassan R (1983) Nasal mucociliary function in different diseases of the nose. J Laryngol Otol 97: 497-502
15. Hauptmann S, Schäfer H, Fritz A, Hauptmann P (1992) Untersuchung der wachstumsbeeinflussenden Wirkung von Wundsalben an der Zellkultur. Hautarzt 43: 432-435
16. Hosemann W, Göde U, Länger F, Wiegand ME (1991) Experimentelle Untersuchungen zur Wundheilung in den Nasennebenhöhlen II. Spontaner Wundverschluss und medikamentöse Effekte im standardisierten Wundmodell. HNO 39: 48-54
17. Kehrl W, Sonnemann U (1998) Dexpanthenol-Nasenspray als wirksames Therapieprinzip zur Behandlung der Rhinitis sicca anterior. Laryngorhinootologie 77: 506-512
18. Kehrl W, Sonnemann U (2000) Verbesserung der Wundheilung nach Nasenoperationen durch kombinierte Anwendung von Xylometazolin und Dexpanthenol. Laryngorhinootologie 79: 151-154
19. Kleinschmidt EG, Witt G (1995) Zur Beurteilung der Mukoziliartä tigkeit mit einem modifizierten Saccharintest. Laryngorhinootologie 74: 286-288
20. Klöcker N, Hanschke W, Toussaint S, Verse T (2001) Scopolamine nasal spray in motion sickness: a randomised, controlled, and cossover study for the compararison of two scopolamine nasal sprays with oral dimenhydrinate and placebo. Eur J Pharm Sci 13: 227-232
21. Klöcker N, Verse T, Rudolph P (2003) Die schleimhautprotektive Wirkung von Dexpanthenol in Nasensprays. Erste Ergebnisse zytotoxischer und zilientoxischer Versuche in vitro. Laryngorhinootologie 82: 177-182
22. Knipping S, Holzhausen HJ, Wollschlager B, Mir Salim PA, Berghaus A (2002) Ultrastrukturelle Veränderungen der Nasenschleimhaut bei primärer ziliarer Dyskinesie. HNO 50: 483-487
23. Kuboyama Y, Suzuki K, Hara T (1997) Nasal lesions incluced by intranasal administration of benzalkonium chloride in rats. J Toxicol Sci 22: 153-160
24. Mercke U (1975) The influence of varying air humidity on mucociliary activity. Acta Otolaryngol 79: 133-139
25. Mercke U, Hakansson CH, Toremalm NG (1974) The influence of temperature on mucociliary activity. Acta Otolaryngol 78: 444-450
26. Passali D, Ciampoli MB (1985) Normal values of mucociliary transport time in young subjects. Int J Pediatr Otorhinolaryngol 9: 151-156
27. Puchelle E, Aug F, Pham QT, Bertrand A (1981) Comparison of three methods for measuring nasal mucociliary clearance in man. Acta Otolaryngol 91: 297-303
28. Sakakura Y, Ukai M, Majima Y, Murai S, Harada T, Miyoshi Y (1983) Nasal mucociliary clearance under various conditions. Acta Otolaryngol 96: 167-173
29. Striebel HW, Toussaint S, Raab C, Klöcker N (1999) Non-invasive methods for PCA in pain management. Acute Pain 2: 36-40
30. Tsikoudas A, Homer JJ (2001) The delivery of topical nasal sprays and drops to the middle meatus: a semi-quantitative analysis. Clin Otolaryngol 26: 294-297
31. van de Donk HJ, van den Heuvel JZ, Merkus FN (1982) The effects of nasal drops and their additives on human nasal mucociliary clearance. Rhinology 20: 127-137
32. Windeler J, Trampisch HJ (1995) Empfehlungen zur Durchführung von Studien zur therapeutischen Äquivalenz. Informatik, Biometrie und Epidemiologie in Medizin und Biologie 4: 350-355